Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4352)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2023 (publication date) through Sep 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang D, Xiao M, Wan ZM, Lin X, Li QY, Zheng SS. Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges. World J Gastrointest Surg 2023; 15(4): 544-552 [PMID: 37206072 DOI: 10.4240/wjgs.v15.i4.544] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v15/i4/544.htm |
| Number | Citing Articles |
| 1 |
Jianxiong Jing, Furui Zhong, Hao Zhang, Guosong Luo, Zongzhi Du. Comparative outcomes of stereotactic body radiotherapy versus radiofrequency ablation in hepatocellular carcinoma within Milan criteria: a systematic review and meta-analysis. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1644001
|
| 2 |
Mansour Bahardoust, Maryam Zolfaghari Dehkharghani, Pouya Ebrahimi, Maryam Najafirashed, Safa Mousavi, Meisam Haghmoradi, Mohsen Khaleghian, Adnan Tizmaghz. Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort study. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-02236-8
|
| 3 |
Jiyong Wei, Yanni Lan, Guipeng Lan, Ronghe Gu. A bibliometric analysis of liver cancer bone metastases: advances in mechanisms of occurrence and treatment options. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1594848
|
| 4 |
Cheng Lin, Yue Wan, Qiang Huo, Dachuan Liu, Xinhua Liu, Hao Liu, Yixuan Zhang, Xiu Cheng. Chemoproteomics reveals Ailanthone directly binds to PKM2 to inhibit the progression of Hepatocellular carcinoma. Phytomedicine 2025; 143: 156886 doi: 10.1016/j.phymed.2025.156886
|
| 5 |
Qi Fan, Pengcheng Wei, Delin Ma, Qian Cheng, Jie Gao, Jiye Zhu, Zhao Li. Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study. Surgery Open Science 2025; 23: 16 doi: 10.1016/j.sopen.2024.12.004
|
| 6 |
Yong Jiang, Le Fan, Yunxia Chai, Feng Xiao, Nan Zhu, Bin Yi. Novel dual-targeted modified polyester albumin nano-carriers enhance the efficacy of hepatocellular carcinoma outcomes after encapsulating lenvatinib. Journal of Biomaterials Applications 2025; doi: 10.1177/08853282251374426
|
| 7 |
Wenli Dang, Tongcan Cui, Guorui Jiao, Jiawei Li, Zhidong Liu. Subcellular organelle-mediated precise delivery of nanomedicines: Advances and applications in cancer therapy. Journal of Drug Delivery Science and Technology 2025; 112: 107261 doi: 10.1016/j.jddst.2025.107261
|
| 8 |
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine. World Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
Abstract(769) |
Core Tip(765) |
Full Article(HTML)(2935)
|
Full Article with Cover (PDF)-3548K(210)
|
Full Article (Word)-242K(26)
|
Audio-234K(16)
|
Peer-Review Report-224K(139)
|
Answering Reviewers-264K(127)
|
Full Article (PDF)-550K(214)
|
Full Article (XML)-38K(141)
|
Times Cited (7)
|
Total Visits (8476)
|
Open
|
| 9 |
Neil B. Newman, Colin M. Court, Alexander A. Parikh. What Is the Optimal Locoregional Approach for Recurrent Hepatocellular Carcinoma?. Journal of Clinical Oncology 2025; 43(9): 1050 doi: 10.1200/JCO-24-02541
|
| 10 |
Jianping Wang, Peipei Cong, Zhipeng Jin, Lingli Liu, Dongxu Sun, Wenjing Zhu, Guangjun Shi. A novel prognostic signature for hepatocellular carcinoma based on SUMOylation-related genes. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-38197-4
|
| 11 |
Xiaocheng Gong, Yunfei Liu, Keying Liang, Zixi Chen, Ke Ding, Li Qiu, Jinfen Wei, Hongli Du. Cucurbitacin I exerts its anticancer effects by inducing cell cycle arrest via the KAT2a-ube2C/E2F1 pathway and inhibiting HepG2-induced macrophage M2 polarization. Biochemical and Biophysical Research Communications 2024; 738: 150508 doi: 10.1016/j.bbrc.2024.150508
|
| 12 |
Tatsuki Kusuhara, Hidetoshi Gon, Kazuki Terashima, Shohei Komatsu, Yoshiro Matsuo, Sunao Tokumaru, Hirochika Toyama, Masahiro Kido, Tomoaki Okimoto, Takumi Fukumoto. ASO Author Refections: The potential role of particle therapy as a therapeutic option for patients with recurrent hepatocellular carcinoma after liver resection. Annals of Surgical Oncology 2025; 32(1): 448 doi: 10.1245/s10434-024-16430-2
|
| 13 |
Ga Ram You, Shin Young Park, Su Hyeon Cho, Sung Bum Cho, Yang Seok Koh, Chang Hun Lee, Hoon Gil Jo, Sung Kyu Choi, Jae Hyun Yoon. Extrahepatic Recurrence After Surgical Resection of Hepatocellular Carcinoma Without Intrahepatic Recurrence: A Multi-Institutional Observational Study. Cancers 2025; 17(9): 1417 doi: 10.3390/cancers17091417
|